MedPath

A Mindfulness-based Intervention to Reduce Stress and Improve Prosocial Skills for Health-care Students

Not Applicable
Completed
Conditions
Mental Health Issue
Registration Number
NCT07110792
Lead Sponsor
University of Geneva, Switzerland
Brief Summary

We aim to study the clinical immediate and long-term efficacy of a web-delivered MBCT-L protocol targeting bachelor and master health-care students in Geneva, as well as to study the correlations of clinical, neuroimaging and biomedical effects of such an intervention.

Primary objective: To evaluate the immediate and long-term effect of MBCT-L on reducing perceived stress and improving pro-social skills for health-care students, compared to a control group.

Secondary objective: To evaluate the immediate and long-term effect of MBCT-L on trait mindfulness, compassion, global psychological well-being, sleep quality, anxiety, depression, satisfaction in studies and resilience, to broaden the clinical understanding of the impact of such an intervention.

Detailed Description

This study is led jointly by Prof. C. Nemitz-Piguet, Dr F. Jermann, and Prof. S. Rudaz, who serve as co-principal investigators.

This study is funded by the Swiss National Science Foundation (Grant number: 32003B_205111 / 1)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
161
Inclusion Criteria
  • Eligibility criteria were applied to recruit second, third- or fourth-year health students in Geneva, Switzerland, who were at least 18 years old, had some interest in mindfulness, were available for the duration of the study, and agreed on refraining from regular mindfulness practice until allocated to the MBCT-L group.
Exclusion Criteria
  • Students were excluded if they had a current depressive episode, post-traumatic stress disorder, psychotic disorder, or substance dependency as identified through the Mini international Neuropsychiatric Interview (MINI). All participants received oral and written information about the trial and signed the informed consent form prior to the beginning of the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Work package 1 (WP1) - Perceived stressT0: baseline T1: 3 months from T0 T2: 9 months from T0

Perceived stress as measured by the Perceived Stress Scale (PSS; score range: 0 -56; a higher score indicates a higher perceived stress level)

Work package 1 (WP1) - Prosocial skillsT0: baseline T1: 3 months from T0 T2: 9 months from T0

Prosocial skills as measured by the Prosocialness Scale for Adults (PBS; score range: 16-80; a higher score indicate a greater tendency towards prosocial behaviors).

Work package 2 (WP2) - Socio-affective Video Task with Resting State (SoVT-Rest)T0: baseline T1: 3 months from T0 T2: 9 months from T0

Cortico-limbic emotion regulation network reactivity to psychological stress as measured by functional MRI (fMRI) in response to the SOVT-Rest

Work package 2 (WP2) - Montreal Imaging Stress Task (MIST)T0: baseline T1: 3 months from T0 T2: 9 months from T0

Cortico-limbic emotion regulation network reactivity to psychological stress as measured by functional MRI (fMRI) in response to the MIST

Work package 3 (WP3) - MetabolicT0: baseline T1: 3 months from T0 T2: 9 months from T0

Metabolic constitutive profiles

Work package 3 (WP3) - LipidT0: baseline T1: 3 months from T0 T2: 9 months from T0

Lipid signalling profiles

Secondary Outcome Measures
NameTimeMethod
WP1 - Trait mindfulnessT0: baseline T1: 3 months from T0 T2: 9 months from T0

Questionnaire: Five Facets of Mindfulness Questionnaire (FFMQ); score range: 39-195.

A higher score indicates a higher level of trait mindfulness

WP1 - CompassionT0: baseline T1: 3 months after T0 T2: 9 months after T0

Sussex-Oxford Compassion Scale; compassion for the self; score range: 20-120 ; compassion for others; score range: 20-120.

A higher score indicates a greater level of compassion

WP1 - Psychological well-beingT0: baseline T1: 3 months from T0 T2: 9 months from T0

Psychological well-being scale; score range 18-108. A higher score indicates a greater psychological well-being

WP1 - InsomniaT0: baseline T1: 3 months from T0 T2: 9 months from T0

Sleep condition indicator; score range: 0-32 A higher score corresponds to better sleep

WP1 - Anxiety and depressionT0: baseline T1: 3 months from T0 T2: 9 months from T0

Hospital Anxiety and Depression Scale; score range: 0-21 for anxiety and 0-21 for depression subscale. Higher scores correspond to higher anxiety and depression

WP1 - Satisfaction with studiesT0: baseline T1: 3 months from T0 T2: 9 months from T0

Scale of satisfaction with Studies; score range 5-35. A higher score indicates a greater degree of contentment with one's academic experience

WP1 - ResilienceT0: baseline T1: 3 months from T0 T2: 9 months from T0

Brief Resilience Scale; score range: 6-30. A higher score indicates a higher level of resilience

WP2 - Grey matter volume and functional connectivity in cortico-limbic emotion regulation networks (sMRI)T0: baseline T1: 3 months from T0 T2: 9 months from T0

Grey matter volume and functional connectivity in cortico-limbic emotion regulation networks (sMRI)

WP2 - Resting State neuroimaging dataT0: baseline T1: 3 months from T0 T2: 9 months from T0

Resting State neuroimaging data

WP3 - CortisolT0: baseline T1: 3 months from T0 T2: 9 months from T0

Capillary and blood cortisol

WP3 - OxytocineT0: baseline T1: 3 months from T0 T2: 9 months from T0

Oxytocine

WP3 - Stress and inflammatory markersT0: baseline T1: 3 months from T0 T2: 9 months from T0

Stress and inflammatory markers

Trial Locations

Locations (1)

University of Geneva

🇨🇭

Geneva, Switzerland

University of Geneva
🇨🇭Geneva, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.